Citations

Clear

9 citation(s) found for "Khalid, Muhammad".

Efficacy and Safety of Daratumumab‐Based Regimens in Multiple Myeloma: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
Khan, A, Ajmal, Hafsa, Khalid, M Mohamed, Babar, Waleed , Shafaqat, Usama, Fida, Tooba , Hassan, Mohammad Aitzaz , Fatima, Sibgha, Akram, Ahmad Sameed, Khan, Abdul Moiz , Ajmal, Hafsa , Khalid, Muhammad , Fatima, Sibgha, Segawa, Fred

Mayo Clinic

eJHaem | July 25, 2026 | Volume: 7 | Issue: 4 | Pages: No page available

10.1002/jha2.70362 | PMID 42502279 Get It

ABSTRACT Introduction Multiple myeloma is a malignant plasma cell disorder predominantly affecting older adults and poses a significant health burden due to its incurable nature, high relapse rate, and associated immune dysfunction. Daratumumab, when added to standard therapy, has shown promising results in large trials. This meta‐analysis compared clinical trials of daratumumab‐containing regimens with standard therapies in the treatment of multiple myeloma. The primary outcomes analyzed were overall response rate (ORR) and progression‐free survival (PFS). Methods A systematic search of PubMed, Scopus, Cochrane CENTRAL, and Google Scholar was performed from January 2015 through December 2024. After screening via Rayyan, data were extracted on an Excel spreadsheet. Quality was assessed using the Cochrane RoB 2.0 tool. Eligible randomized controlled trials (RCTs) were included and analyzed using RevMan 5.4. Outcomes assessed were ORR and PFS. Adverse effects were compared among therapies. Results Nine Phase III RCTs ( n = 4556) were included, with a mean follow‐up of 44.3 months. Daratumumab‐based regimens significantly improved PFS (HR 0.55, 95% CI 0.46–0.66) but did not confer a statistically significant overall survival advantage (RR 0.90, p = 0.25). ORR was inconsistent, with five trials favoring daratumumab and one favoring control. Safety analyses showed higher risks of pneumonia (RR 1.74, p < 0.0001), secondary malignancies (RR 1.46, p = 0.003), neutropenia (RR 1.25, p = 0.006), and thrombocytopenia (RR 1.17, p = 0.01). Lymphopenia showed a numerical increase but was not statistically significant. Conclusion Daratumumab plus standard therapy regimens significantly improve PFS in multiple myeloma, though the overall survival benefit remains unproven. While efficacy is notable, treatment is associated with increased risks of infections, hematological toxicities, and secondary malignancies, highlighting the need for careful patient selection and vigilant monitoring. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
A Systematic Review of Pain Phenotypes in Individuals with Parkinson’s Disease (P4-7.010)
Patel, Utsav , Inggas, Made AM, Arya, Prakriti , Karve, Sanidhya S. , Turjman, Tawfiq , Turjman, Hisham , Khalid, Muhammad , Wijaya, Jeremiah Hilkiah , Inggas, Made Agus Mahendra , Khalid, Muhammad, Kaye, Alan D. , Kataria, Saurabh

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211848 Get It

HIV mortality trends among the United States population, from 1999–2023: a CDC wonder database study
Ekpendu, Abuoma Cherry , Asghar, Muhammad Sohaib , Shaik, Afsana Ansari, Khalid, Muhammad Zain , Duharte, Maria, Duharte-Vidaurre, Luis, Brands, Chad K., Asghar, Muhammad S , Shaik, Afsana Ansari, Hegazi, Moustafa

Mayo Clinic

Infectious Diseases | March 17, 2025 | Volume: 57 | Issue: 5 | Pages: 444-463

10.1080/23744235.2025.2477700 | PMID 40094274 Get It

The Role of Platelet Rich Plasma in the Management of Vertebrogenic and Discogenic Pain (P5-13.004)
Patel, Utsav , Yabut, Kevin , Ayub, Muhammad Talha , Khalid, Muhammad , Aslam, Tooba, Kataria, Saurabh , Wijaya, Jeremiah Hilkiah , Ayub, Muhammad, Khalid, Muhammad, Kaye, Alan D.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000208296 Get It

Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study
Jadoon, Sarosh Khan , Soomro, Rufina , Khan, Raja Muhammad Ijaz , Iqbal, Sadia, Yasmin, Farah , Najeeb, Hala , Cho, Namiya, Resham, Hasan, Syeda Fatima Saba , Khalid, Muhammad Zain , Alvi, Sarosh , Rizvi, Ahsan Mujtaba, Asghar, Muhammad Sohaib , Ahsan, Muhammad Nadeem , Saleem, Nida , Shaikh, Taha Gul , Alvi, Sarosh , Rizvi, Ahsan Mujtaba

Mayo Clinic

Medicine | May 18, 2023 | Volume: 102 | Issue: 20 | Pages: e33811

10.1097/md.0000000000033811 | PMID 37335707 Get It

Inflammatory conditions play part in the progression of malignancies, and markers signifying growth of these factors can indicate prognosis. Neutrophil-to-lymphocyte (NLR) is used as a marker of subclinical inflammation that may become an integral part of workup to indicate prognosis and associated pathology. This study aims to explore the association of NLR ratio with clinical characteristics, radiological assessment and staging, histopathology, and disease outcomes of breast cancer. A retrospective cohort study was conducted in a tertiary care center to include breast cancer patients that were diagnosed between January 2001 and December 2020. Data including tumor size, lymph nodes, metastasis, histological grading, ER/PR/HER2-neu status, molecular subtypes, clinical staging); nodal findings (sentinel and axillary); pathology from frozen section; and disease outcomes were assessed. Multivariable regression and Kaplan–Meier survival curves were employed to indicate the association of NLR with breast cancer features and disease-free survival. A total of 2050 patients had a median age of 50 years, median NLR levels of 2.14, most common pathology ductal followed by lobular, and most common site of metastasis being lungs followed by bones. Disease-free rate was 7.6%, and a recurrence rate of 1.8%, while 1.6% deaths were reported. NLR was found associated with age, treatment outcomes, tumor size, lymph nodes, metastasis and clinical staging. Other positive correlations were with Ki67 proliferation index, molecular subtypes, and tumor size on frozen section (at transverse and craniocaudal dimensions). Negative correlations were seen with estrogen and progesterone receptors. However, NLR was not found predictable of disease-free survival (P = .160). Significant predictors of disease-free survival were histological grading, ER, PR status, molecular subtype, and Ki67 proliferation index. NLR being a readily available marker has shown novel findings in its association with tumor staging, disease outcomes and characteristics of breast malignancy.
Machine Learning Models for Predicting the Outcomes of Surgical Treatment of Colorectal Liver Metastases
Moaven, Omeed , Corvera, Carlos U. , Shen, Perry , Moaven, Omeed , Tavolara, Thomas Erol , Valenzuela, Cristian D. , Cheung, Tan To , Cha, Charles , Stauffer, John , Niazi, Muhammad Khalid Khan , Gürcan, Metin N.

Mayo Clinic

Journal of the American College of Surgeons | February 2, 2023 | Volume: 236 | Issue: 4 | Pages: 884-893

10.1097/xcs.0000000000000573 | PMID 36727981 Get It

BACKGROUND: Surgical intervention remains the cornerstone of a multidisciplinary approach in the treatment of colorectal liver metastases (CLM). Nevertheless, patient outcomes vary greatly. While predictive tools can assist decision-making and patient counseling, decades of efforts have yet to result in generating a universally adopted tool in clinical practice. STUDY DESIGN: An international collaborative database of CLM patients who underwent surgical therapy between 2000 and 2018 was used to select 1,004 operations for this study. Two different machine learning methods were applied to construct 2 predictive models for recurrence and death, using 128 clinicopathologic variables: gradient-boosted trees (GBTs) and logistic regression with bootstrapping (LRB) in a leave-one-out cross-validation. RESULTS: Median survival after resection was 47.2 months, and disease-free survival was 19.0 months, with a median follow-up of 32.0 months in the cohort. Both models had good predictive power, with GBT demonstrating a superior performance in predicting overall survival (area under the receiver operating curve [AUC] 0.773, 95% CI 0.743 to 0.801 vs LRB: AUC 0.648, 95% CI 0.614 to 0.682) and recurrence (AUC 0.635, 95% CI 0.599 to 0.669 vs LRB: AUC 0.570, 95% CI 0.535 to 0.601). Similarly, better performances were observed predicting 3- and 5-year survival, as well as 3- and 5-year recurrence, with GBT methods generating higher AUCs. CONCLUSIONS: Machine learning provides powerful tools to create predictive models of survival and recurrence after surgery for CLM. The effectiveness of both machine learning models varies, but on most occasions, GBT outperforms LRB. Prospective validation of these models lays the groundwork to adopt them in clinical practice.
Abstract TP314: Baseline Thrombocytopenia in Patients With Acute Coronary Syndrome: Does it Affect Following Cerebrovascular Event Rates?
Khalid, Muhammad, Fortuin, David, Chao, Chieh‐Ju , Chiang, Chia‐Chun

Mayo Clinic

Stroke | June 21, 2021 | Volume: 51 | Issue: Suppl_1 | Pages: No page available

10.1161/str.51.suppl_1.tp314 Get It

Introduction: Baseline thrombocytopenia (TP) is a common condition in patients with acute coronary syndrome (ACS) and acute ischemic stroke and has been shown to increase mortality. The effect of baseline TP on cerebrovascular events following initial ACS event is not well studied. Methods: We retrospectively reviewed all patients identified from the institutional NCDR Chest Pain registry database at Mayo Clinic Arizona from Oct 2015 to Sep 2018. Patients were classified into TP (platelet <150) and control (platelet > 150) groups for clinical outcome (stroke/TIA and bleeding events) analysis. P-value < 0.05 is considered significant. Results: Five hundred and thirty-six patients were included for final analysis. Patient demographics and clinical outcomes are shown in Table 1. The rates of dual antiplatelet therapy (DAPT) prescription at discharge (TP vs. control: 68.1% and 75.4%, P=0.197), stroke/TIA (1.3% vs. 2.4%, P=1.000) and recurrent myocardial infarction (11.1% vs. 11.2%, P=1.000) were similar between the two groups. The TP group has more bleeding events compared to control (Figure 1). Conclusions: In patients with ACS, baseline TP does not affect stroke/TIA events but is associated with higher bleeding rate. The results could not be explained by the DAPT or anticoagulation use alone. Further studies are needed to investigate the pathophysiologic correlation of thrombocytopenia, DAPT, and stroke in ACS patients.
Attitude adjustments after global health inter-professional student team experiences
Skolka, Michael , Hennrikus, William L. , Skolka, Michael P , Khalid, Muhammad , Hennrikus, Eileen

Mayo Clinic

Medicine | April 18, 2020 | Volume: 99 | Issue: 16 | Pages: e19633

10.1097/md.0000000000019633 | PMID 32311933 Get It

Abstract How medical inter-professional (IP) education should be introduced to students is still a matter of research. We evaluated IP student attitudes before and after a busy “hands-on” clinical experience. During 3 separate trips, first/second year medical and physician assistant students and third/fourth year nursing students traveled to Central America to work together for 1 week in an underserved clinical setting. Student opinions on inter-professional education were obtained before and after Brigade-1 using the Readiness for Inter-professional Learning Scale validated questionnaire. From these results, a modified version of the survey was developed that included quantitative and qualitative responses. For brigades-2 and -3, students received this modified version of the survey pre and post brigade. Quantitative data was analyzed via paired student t test, and qualitative data was analyzed to identify emerging themes using constant comparative methodology by three separate investigators. No significant quantitative differences between IP student groups were observed in their evaluation of the importance of inter-professional education either before or after the brigades. Qualitative data noted pre-brigade expectations of positive IP, experiential and patient-centered cultural learning. Pre- and post-brigade student perspectives maintained a strong belief that high functioning IP care benefited the patient. Post-brigade perspectives revealed a shift in attitude from purely positive expectations to more practical aspects of teamwork, respect, and interpersonal relationships. Students believe that patient care benefits from IP collaboration. After a busy clinical experience requiring collaboration, students realized that functional teams require appropriate skills, roles, and respectful interpersonal relationships.
Physician characteristics correlate with hospital readmission rates
Skolka, Michael , Lehman, Erik , Hennrikus, Eileen , Skolka, Michael P , Khalid, Muhammad

Mayo Clinic

Medicine | March 9, 2020 | Volume: 99 | Issue: 10 | Pages: e19363

10.1097/md.0000000000019363 | PMID 32150080 Get It

Abstract Hospital readmission rates are used as a metric to measure quality patient care. While several tools predict readmissions based on patient-specific characteristics, this study assesses if physician characteristics correlate with hospital readmission rates. In a 5-year retrospective electronic record review at a single institution, 31 internal medicine attending physicians’ discharges were tracked for a total of 70 physician years, and 15,933 hospital discharges. Each physician's yearly 7-day, 8 to 30-day, and 30-day readmission rates were compared. Each rate was also correlated with years of post-graduate clinical experience, discharge volume, physician sex, and fiscal year. Individual physicians had significantly different 7-day, 8 to 30-day, and 30-day readmission rates from each other. The rates were not related to sex, years after post-graduate training, or fiscal year. However, physician patient volume correlated with 7-day readmission rates. Physicians who discharged ≤100 patients per year had a higher 7-day readmission rate than physicians who discharged >100 patients per year. This correlation with patient volume did not hold for the 8 to 30-day and 30-day readmission rates. Individual physicians differ in their patient readmission rates in 7-day, 8 to 30-day, and 30-day categories. A critical level of a physician's hospital activity, as reflected by the number of patient discharges per year (>100), results in lower 7-day readmission rates. Sex, post-graduate years of clinical experience, and fiscal year did not play a role. The lack of correlation between each physicians’ 7-day and 8 to 30-day readmission rates suggests that different physician factors are involved in these 2 rates.